
Guardian Pharmacy Services, Inc.: updates and filings
Price
$49.43
November 16, 2026Market cap $3.1B
What Ploutos Investor adds for Guardian Pharmacy Services
Part of Ploutos Investor, €9.99 a month
- The full history: 2 fiscal years, from 2024
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has risen 24% since Nov 5, 2026, when the 10-Q these figures come from was filed ($39.87 then, $49.43 on Nov 16, 2026). The figures date from before that move.10-Q
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
September 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operationsForm8-K
- Nov 5, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Sep 28, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Sep 10, 2026Other material eventsForm8-K
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jun 22, 2026Officer or director change, Regulation FD disclosureForm8-K
- May 28, 2026Material agreement entered, new material financial obligationForm8-K
- May 7, 2026Shareholder voteForm8-K
- May 6, 2026Shares registered for employeesFormS-8
- May 6, 2026Shelf registration for future offeringsFormS-3ASR
- May 6, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 6, 2026Results of operationsForm8-K
- May 6, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Mar 26, 2026Additional annual meeting materialFormDEFA14A
- Mar 26, 2026Annual meeting proxy statementFormDEF 14A
- Mar 24, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Mar 23, 2026Material agreement entered, other material eventsForm8-K
- Mar 19, 2026FilingFormS-3MEF
- Mar 11, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 11, 2026Results of operationsForm8-K
- Feb 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 10, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 21, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations | Document |
| Nov 5, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Sep 28, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Sep 10, 2026 | 8-K | Other material events | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jun 22, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| May 28, 2026 | 8-K | Material agreement entered, new material financial obligation | Document |
| May 7, 2026 | 8-K | Shareholder vote | Document |
| May 6, 2026 | S-8 | Shares registered for employees | Document |
| May 6, 2026 | S-3ASR | Shelf registration for future offerings | Document |
| May 6, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 6, 2026 | 8-K | Results of operations | Document |
| May 6, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Mar 26, 2026 | DEFA14A | Additional annual meeting material | Document |
| Mar 26, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 24, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Mar 23, 2026 | 8-K | Material agreement entered, other material events | Document |
| Mar 19, 2026 | S-3MEF | Filing | Document |
| Mar 11, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 11, 2026 | 8-K | Results of operations | Document |
| Feb 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 10, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 21, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 13, 2020.
The full analysis
What do Guardian Pharmacy Services's filings show?
The filings are where every one of Guardian Pharmacy Services's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.